title: Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia.
abstract: BACKGROUND
  An interesting finding in the epidemiology of human immunodeficiency virus (HIV) infection is that certain mutations in genes coding for chemokines, and their receptors and ligands, may confer resistance or susceptibility to HIV-1 infection and acquired immunodeficiency syndrome (AIDS) progression. The mutation most frequently studied is stromal cell-derived factor (SDF)1-3'A, a single nucleotide polymorphism in the 3' untranslated region at the 801 position of the SDF1 gene, which seems to be associated with susceptibility or resistance to diseases, including AIDS. We examined the frequency of the above polymorphisms in the Tunisian population, and evaluated their contribution to a protective genetic background against HIV infection and progression.
  
  
  METHODS
  One hundred forty blood samples from HIV-infected patients from the Cellular Immunology Research Laboratory at the National Blood Transfusion Center were compared with those of 164 random blood donors from the same center. Genotyping was initially performed by polymerase chain reaction (PCR) analysis. SDF1 PCR product genomic regions were further subjected to restriction fragment length polymorphism analysis for genotype determination. Screening for the SDF1 polymorphism in the HIV-infected population yielded 56 heterozygous (40%), 52 mutation homozygous (37.1%), and 32 wild-type homozygous (22.8%) subjects. In contrast, in our healthy population, we found 70/164 heterozygous (42.6%), nine mutation homozygous (5.4%), and 85 wild-type homozygous (51.8%) subjects. The allele frequencies in the HIV-infected and healthy populations were f(SD1 3'A) = 57.1%, f(SDF1) = 42.8%, f(SDF1 3'A) = 26.8%, and f(SDF1) = 73.1%, respectively. The allelic and genotypic frequencies of the SDF1 3'A in our population show significantly higher distribution profiles compared with those observed in other Caucasian, European, and African American populations. Our results were examined by χ(2) test and appear to confirm an association between polymorphism and AIDS progression. A higher odds ratio (>1) was found for the SDF1-3'A allele than for the wild-type allele (<1).
  
  
  CONCLUSIONS
  This result seems to confirm that the SDF1-3'A allele is associated with acceleration and progression from HIV infection to AIDS in the Tunisian population.
authors.affiliation: Cellular Immunology and Cytometry, National Blood Transfusion Center, Tunis, Tunisia.
authors.forename: Sameh
authors.initials: S
authors.lastname: Amara
authors.forename: Jorge
authors.initials: J
authors.lastname: Domenech
authors.forename: Faouzi
authors.initials: F
authors.lastname: Jenhani
references.citation: Genes Immun. 2001 Nov;2(7):408-10
references.pmid: 11704809
references.citation: Science. 1998 Jan 16;279(5349):389-93
references.pmid: 9430590
references.citation: J Clin Virol. 2007 Mar;38(3):198-203
references.pmid: 17240189
references.citation: AIDS Res Hum Retroviruses. 2001 May 20;17(8):663-6
references.pmid: 11429106
references.citation: J Hum Genet. 2002;47(11):585-9
references.pmid: 12436194
references.citation: Nat Med. 1998 Jul;4(7):786-93
references.pmid: 9662369
references.citation: Virology. 2004 Jun 20;324(1):140-50
references.pmid: 15183061
references.citation: FEBS Lett. 1998 Apr 17;426(2):271-8
references.pmid: 9599023
references.citation: Biochem Mol Med. 1997 Dec;62(2):197-202
references.pmid: 9441873
references.citation: Nature. 1996 Jun 20;381(6584):661-6
references.pmid: 8649511
references.citation: Lung Cancer. 2005 Sep;49(3):311-5
references.pmid: 15955592
references.citation: Ann Intern Med. 2001 Nov 6;135(9):782-95
references.pmid: 11694103
references.citation: Semin Immunol. 2006 Dec;18(6):387-403
references.pmid: 16978874
references.citation: Am J Hum Genet. 1999 Oct;65(4):1047-53
references.pmid: 10486323
references.citation: Curr HIV Res. 2009 Jul;7(4):384-9
references.pmid: 19601773
references.citation: AIDS. 2001 Jul 27;15(11):1343-52
references.pmid: 11504955
references.citation: J Med Virol. 1999 May;58(1):54-8
references.pmid: 10223546
references.citation: Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15006-10
references.pmid: 14657379
references.citation: J Infect Dis. 2002 Oct 1;186(7):922-31
references.pmid: 12232832
references.citation: J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):521-6
references.pmid: 16284526
references.citation: Science. 1996 May 10;272(5263):872-7
references.pmid: 8629022
references.citation: Virology. 2007 Dec 5;369(1):214-25
references.pmid: 17765942
references.citation: Biomed Pharmacother. 2008 Jan;62(1):26-30
references.pmid: 17560067
references.citation: J Virol. 2001 May;75(9):4258-67
references.pmid: 11287575
references.citation: Genet Test. 2004 Spring;8(1):73-6
references.pmid: 15140377
references.citation: J Clin Virol. 2005 Dec;34(4):310-4
references.pmid: 16286055
references.citation: AIDS Res Hum Retroviruses. 2001 May 1;17(7):587-95
references.pmid: 11375054
references.citation: Int J Immunogenet. 2006 Apr;33(2):127-33
references.pmid: 16611258